Cited by 256Cannabis and Cannabinoid ResearchRadiopharmaceutical Chemistry and ApplicationsNeuropeptides and Animal Physiology

The DOI matches its Crossref record; 12 of the 15 references it cites were found in a registry or an index.

123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors

Gatley, S.John, Gifford, Andrew N., Volkow, Nora D., Lan, Ruoxi, Makriyannis, Alexandros·1996·European Journal of Pharmacology

DOI 10.1016/0014-2999(96)00279-8

Open this paper in CoChat — free account

Abstract

We have investigated the binding of 123I-labeled N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methy l-1 H-pyrazole-3-carboxamide (AM251), an analog of the cannabinoid receptor antagonist SR141716A [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-me thyl-1 H-pyrazole-3-carboxamide] in the mouse brain. Following intravenous injection, the peak whole-brain uptake of about 1% of the administered activity occurred at about 2 h. By 8 h radioactivity in brain had declined to about half its peak value. High-performance liquid chromatographic analysis showed that > 70% of radioactivity extracted from brain at 2 h was still present as [123I]AM251. Co-injection of SR141716A inhibited the in vivo brain binding of [123I]AM251 dose dependently. At 2 mg/kg, the highest dose that could be tested, inhibition was 50% at 2 h post-administration. The ED50 value calculated assuming that 2 mg/kg gave near-maximal inhibition was about 0.1 mg/kg. In contrast to the brain, radioactivity in other major organs (blood, liver, kidney, heart and lung) was little affected by SR141716A. The regional binding of [123I]AM251 in the brain was consistent with the published distribution of cannabinoid receptors in rat brain, in that the order was hippocampus, striatum > cerebellum > brain stem. delta 9-Tetrahydrocannabinol co-administered intravenously at 10 mg/kg, a dose which induced catalepsy and decreased locomotor activity, decreased the 2 h brain uptake of [123I]AM251 by 10%, but this was not significant (P = 0.08). In in vitro binding assays with mouse hippocampal membranes, tetrahydrocannabinol inhibited binding of [123I]AM251 with an IC50 value of about 700 nM, compared with about 0.2 nM for SR141716A.

Integrity signals

Registry

Crossref · 10.1016/0014-2999(96)00279-8

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762
Health aspects of cannabis
Hollister, L. E. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 500
SPECT imaging of striatal dopamine release after amphetamine challenge.
Laruelle, M. A., Abi‐Dargham, A., van Dyck, C. H., Rosenblatt, W., Zea‐Ponce, Y., Zoghbi, S. S., Baldwin, R. M., Charney, D. S., Hoffer, P. B., & Kung, H. F. (1995) · PubMed · Cited by 333
Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol.
Compton, D. M., Gold, L. H., Ward, S. J., Balster, R. L., & Martin, B. R. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10448-5 · Cited by 288
Graphical, Kinetic, and Equilibrium Analyses of in vivo [ 123 I]β-CIT Binding to Dopamine Transporters in Healthy Human Subjects
Laruelle, M. A., Wallace, E. A., Seibyl, J. P., Baldwin, R. M., Zea‐Ponce, Y., Zoghbi, S. S., Neumeyer, J. L., Charney, D. S., Hoffer, P. B., & Innis, R. B. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.131 · Cited by 268

Show all 15 references

Research works printed but not linked: 4

Chait, 1992, Effects of smoked marijuana on human performance: a critical review, 387
Johnston, 1995, National Survey Results on Drug Use from the Monitoring the Future Study, 1975–1994, Vol. 1
Lichtmann, 1995, The novel cannabinoid antagonist SR141716A blocks delta-9 THC impairment of working memory in rats, Soc. Neurosci. Abstr., 21, 167
Marciniak, 1991, Fluorine-18 labeled tetrahydrocannabinol: synthesis and PET studies in a baboon, J. Label. Compd., 30, 413

Sorted by citations

Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno‐Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,595
Retrograde Inhibition of Presynaptic Calcium Influx by Endogenous Cannabinoids at Excitatory Synapses onto Purkinje Cells
Kreitzer, A. C., & Regehr, W. G. (2001) · Neuron · doi:10.1016/s0896-6273(01)00246-x · Cited by 899
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 891
Neocortical LTD via Coincident Activation of Presynaptic NMDA and Cannabinoid Receptors
Sjöström, P. J., Turrigiano, G. G., & Nelson, S. B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00476-8 · Cited by 629
Activation of CB 2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS
Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne, D. A., Kwan, J., Mata, H. P., Vanderah, T. W., Lai, J., Porreca, F., Makriyannis, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834309100 · Cited by 491
Self-citation
A Cooperative Switch Determines the Sign of Synaptic Plasticity in Distal Dendrites of Neocortical Pyramidal Neurons
Sjöström, P. J., & Häusser, M. (2006) · Neuron · doi:10.1016/j.neuron.2006.06.017 · Cited by 433
CB2 cannabinoid receptor-mediated peripheral antinociception
Malan, P. T., Ibrahim, M. M., Deng, H., Liu, Q., Mata, H. P., Vanderah, T., Porreca, F., & Makriyannis, A. (2001) · Pain · doi:10.1016/s0304-3959(01)00321-9 · Cited by 391
Self-citation
Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice
Marzo, V. D., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., Zimmer, A., & Martin, B. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752434.x · Cited by 394
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study
Neumeister, A., Normandin, M. D., Pietrzak, R. H., Piomelli, D., Zheng, M. Q., Gujarro-Anton, A., Potenza, M. N., Bailey, C. R., Lin, S. F., Najafzadeh, S., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.61 · Cited by 361
Cerebellar Depolarization-Induced Suppression of Inhibition Is Mediated by Endogenous Cannabinoids
Kreitzer, A. C., & Regehr, W. G. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-20-j0005.2001 · Cited by 353
The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications
Lambert, D. M., & Fowler, C. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058183t · Cited by 354
Cannabinoids, opioids and eating behavior: The molecular face of hedonism?
Cota, D., Tschöp, M. H., Horvath, T. L., & Levine, A. S. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.10.004 · Cited by 330
[ 18 F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor
Burns, H. D., Laere, K. V., Bohorquez, S. M. S., Hamill, T. G., Bormans, G. M., Eng, W., Gibson, R. E., Ryan, C. N., Connolly, B., Patel, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703472104 · Cited by 317
Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide
Facchinetti, F., Giudice, E. D., Furegato, S., Passarotto, M., & Leon, A. (2002) · Glia · doi:10.1002/glia.10177 · Cited by 280
The endocannabinoid system in brain reward processes
Solinas, M., Goldberg, S. R., & Piomelli, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.130 · Cited by 251
A runner's high depends on cannabinoid receptors in mice
Fuss, J., Steinle, J., Bindila, L., Auer, M. K., Kirchherr, H., Lutz, B., & Gass, P. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514996112 · Cited by 229
Cannabinoids Acting on CB1 Receptors Decrease Contractile Performance in Human Atrial Muscle
Bonz, A. W., Laser, M., Küllmer, S., Kniesch, S., Babin–Ebell, J., Popp, V., Ertl, G., & Wagner, J. A. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200304000-00020 · Cited by 234
Endocannabinoids in the regulation of appetite and body weight
Kirkham, T. C. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00004 · Cited by 224
Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers
Hájos, N., & Freund, T. F. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00157-0 · Cited by 201
Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice
Hildebrandt, A. L., Kelly-Sullivan, D., & Black, S. C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01343-8 · Cited by 181
Cannabinoids and anxiety
Moreira, F. A., & Wotjak, C. T. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_16 · Cited by 177
CB2 cannabinoid receptor mediation of antinociception
Ibrahim, M. M., Rude, M. L., Stagg, N. J., Mata, H. P., Lai, J. Y., Vanderah, T. W., Porreca, F., Buckley, N. E., Makriyannis, A., & Malan, P. T. (2006) · Pain · doi:10.1016/j.pain.2005.12.018 · Cited by 173
Self-citation
Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis
Steiner, M. S., & Wotjak, C. T. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00433-0 · Cited by 174
Endocannabinoid signaling is critical for habit formation
Hilário, M. R. F. (2007) · Frontiers in Integrative Neuroscience · doi:10.3389/neuro.07.006.2007 · Cited by 164
“Finally, blocking CB1 receptors specifically during training (Gatley et al., 1996) was sufficient to impede habit formation in animals trained under interval schedules.”
On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment
Stern, C. A. J., Gazarini, L., Takahashi, R. N., Guimarães, F. S., & Bertoglio, L. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.63 · Cited by 156
A role for cannabinoid CB1 receptors in mood and anxiety disorders
Witkin, J. M., Tzavara, E. T., & Nomikos, G. G. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00005 · Cited by 160
Novel time-dependent vascular actions of Δ9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma
O’Sullivan, S. E., Tarling, E. J., Bennett, A. J., Kendall, D. A., & Randall, M. D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.121 · Cited by 159
Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle
Eckardt, K., Sell, H., Taube, A., Koenen, M., Platzbecker, B., Cramer, A., Horrighs, A., Lehtonen, M., Tennagels, N., & Eckel, J. (2008) · Diabetologia · doi:10.1007/s00125-008-1240-4 · Cited by 153
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition
Scherma, M., Medalie, J., Fratta, W., Vadivel, S. K., Makriyannis, A., Piomelli, D., Mikics, É., Haller, J., Yaşar, S., Tanda, G., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.08.011 · Cited by 154
Self-citation
Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction
de Oliveira Alvares, L., Pasqualini Genro, B., Diehl, F., Molina, V. A., & Quillfeldt, J. A. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.005 · Cited by 143
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract
Massa, F., Storr, M., & Lutz, B. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0698-5 · Cited by 142
Effects of cannabinoid receptor‐2 activation on accelerated gastrointestinal transit in lipopolysaccharide‐treated rats
Mathison, R., Ho, W., Pittman, Q. J., Davison, J. S., & Sharkey, K. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705889 · Cited by 144
Endocannabinoids Activate Transient Receptor Potential Vanilloid 1 Receptors to Reduce Hyperdopaminergia-Related Hyperactivity: Therapeutic Implications
Tzavara, E. T., Li, D. L., Moutsimilli, L., Bisogno, T., Marzo, V. D., Phebus, L. A., Nomikos, G. G., & Bruno Giros, A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.019 · Cited by 141
Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors
Gatley, S. J., Lan, R., Pyatt, B. E., Gifford, A. N., Volkow, N. D., & Makriyannis, A. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00690-5 · Cited by 140
Self-citation
Novel bioactive metabolites of dipyrone (metamizol)
Rogosch, T., Sinning, C., Podlewski, A., Watzer, B., Schlosburg, J. E., Lichtman, A. H., Cascio, M. G., Bisogno, T., Marzo, V. D., Nüsing, R. M., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.11.028 · Cited by 139
Reinforcement Learning With Modulated Spike Timing–Dependent Synaptic Plasticity
Farries, M. A., & Fairhall, A. L. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00364.2007 · Cited by 135
The role of cannabinoids in adult neurogenesis
Prenderville, J. A., Kelly, A. M., & Downer, E. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13186 · Cited by 136
Role of Cannabinoid Type 1 Receptors in Locomotor Activity and Striatal Signaling in Response to Psychostimulants
Corbillé, A.-G., Valjent, E., Marsicano, G., Ledent, C. A., Lutz, B., Hervé, D., & Girault, J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3936-06.2007 · Cited by 126
CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health
Cota, D. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.764 · Cited by 134
A role for endocannabinoids in indomethacin-induced spinal antinociception
Gühring, H., Hamza, M., Sergejeva, M., Ateş, M., Kotalla, C., Ledent, C. A., & Brune, K. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02485-8 · Cited by 121
The Endocannabinoid System and Extinction Learning
Lutz, B. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8004-x · Cited by 124
Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain
Guindon, J., Guijarro, A. I., Piomelli, D., & Hohmann, A. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01192.x · Cited by 120
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions.
Pistis, M., Perra, S., Pillolla, G., Melis, M., Gessa, G., & Muntoni, A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.08.003 · Cited by 124
Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed
Poblete, I. M., Orliac, M. L., Briones, R., Adler‐Graschinsky, E., & Huidobro-Toro, J. P. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.094292 · Cited by 112
Effects of Cannabinoids on Preimplantation Mouse Embryo Development and Implantation are Mediated by Brain-Type Cannabinoid Receptors1
Paria, B. C., Ma, W., Andrenyak, D. M., Schmid, P. C., Schmid, H. H. O., Moody, D. E., Deng, H., Makriyannis, A., & Dey, S. K. (1998) · Biology of Reproduction · doi:10.1095/biolreprod58.6.1490 · Cited by 113
Self-citation
Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids
Hanuš, L. O. (2008) · Medicinal Research Reviews · doi:10.1002/med.20135 · Cited by 117
Neurochemical basis of cannabis addiction
Maldonado, R. J., Berrendero, F., Ozaita, A., & Robledo, P. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.035 · Cited by 113
A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders
Witkin, J. M., Tzavara, E. T., Davis, R. J., Li, X., & Nomikos, G. G. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.10.006 · Cited by 110
Amnestic effect of intrahippocampal AM251, a CB1-selective blocker, in the inhibitory avoidance, but not in the open field habituation task, in rats
DEOLIVEIRAALVARES, L., De-Oliveira, L. M., de Almeida, C. C. S., Diehl, F., Genro, B. P., Lanziotti, V. M. N. B., & Quillfeldt, J. A. (2004) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2004.10.002 · Cited by 108
Cannabinoid Receptor Blockade Reveals Parallel Plasticity Mechanisms in Different Layers of Mouse Visual Cortex
Liu, C.-H., Heynen, A. J., Shuler, M. G. H., & Bear, M. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.02.020 · Cited by 110
Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand
Terry, G. E., Liow, J., Zoghbi, S. S., Hirvonen, J., Farris, A. G., Lerner, A., Tauscher, J. T., Schaus, J. M., Phebus, L. A., Felder, C. C., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.059 · Cited by 106
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain
Guindon, J., Léan, A. D., & Beaulieu, P. (2006) · Pain · doi:10.1016/j.pain.2005.12.007 · Cited by 107
The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen
Scorticati, C., Fernández‐Solari, J., Laurentiis, A. D., Mohn, C. E., Prestifilippo, J. P., Lasaga, M., Seilicovich, A., Billi, S. C., Franchi, A. M., McCann, S. M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404366101 · Cited by 108
The antinociceptive effects of intraplantar injections of 2‐arachidonoyl glycerol are mediated by cannabinoid CB2receptors
Guindon, J., Desroches, J., & Beaulieu, P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706990 · Cited by 102
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids
Puighermanal, E., Busquets-García, A., Maldonado, R. J., & Ozaita, A. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0384 · Cited by 104
Pharmacotherapeutic targeting of the endocannabinoid signaling system: Drugs for obesity and the metabolic syndrome
Vemuri, K. V., Janero, D. R., & Makriyannis, A. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.012 · Cited by 103
Self-citation
Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-na??ve and plus-maze-experienced mice
Rodgers, R. J., Evans, P., & Murphy, A. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00013 · Cited by 101
Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory
Clarke, J. R., Rossato, J. I., Monteiro, S., Bevilaqua, L. R. M., Izquierdo, I., & Cammarota, M. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.04.009 · Cited by 97
Endocannabinoid-Dependent Neocortical Layer-5 LTD in the Absence of Postsynaptic Spiking
Sjöström, P. J., Turrigiano, G. G., & Nelson, S. B. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00376.2004 · Cited by 97
Endocannabinoid system involvement in brain reward processes related to drug abuse
Solinas, M., Yaşar, S., & Goldberg, S. R. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.005 · Cited by 102
AM251, a selective antagonist of the CB1 receptor, inhibits the induction of long-term potentiation and induces retrograde amnesia in rats
Alvares, L. D. O., Genro, B. P., Breda, R. V., Pedroso, M. F., da Costa, J. C., & Quillfeldt, J. A. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.101 · Cited by 95
Topical cannabinoid enhances topical morphine antinociception
Yeşilyurt, Ö., Dogrul, A., Gül, H., Seyrek, M., Kusmez, O., Özkan, Y., & Yıldız, O. (2003) · Pain · doi:10.1016/s0304-3959(03)00245-8 · Cited by 95
The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats
Shoaib, M. C. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.10.011 · Cited by 93
The role of CB1 in immune modulation by cannabinoids
Kaplan, B. L. F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.004 · Cited by 92
Endocannabinoid Enhancement Protects against Kainic Acid-Induced Seizures and Associated Brain Damage
Karanian, D. A., Karim, S. L., Wood, J. T., Williams, J. S., Lin, S., Makriyannis, A., & Bahr, B. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120147 · Cited by 92
Self-citation
Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain
Guindon, J., & Beaulieu, P. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.12.002 · Cited by 90
Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand
Lan, R., Lu, Q., Fan, P., Gatley, J. S., Volkow, N. D., Fernando, S. R., Pertwee, R. G., & Makriyannis, A. (1999) · AAPS PharmSci · doi:10.1208/ps010204 · Cited by 98
Self-citation
Regulation of Energy Homeostasis by Bombesin Receptor Subtype-3: Selective Receptor Agonists for the Treatment of Obesity
Guan, X.-M., Chen, H., Dobbelaar, P. H., Dong, Y., Fong, T. M., Gagen, K., Gorski, J. N., He, S., Howard, A. D., Jian, T., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.12.008 · Cited by 89
Role of cannabinoids in the regulation of bone remodeling
Idris, A. I., & Ralston, S. H. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00136 · Cited by 89
The PET Radioligand [11C]MePPEP Binds Reversibly and with High Specific Signal to Cannabinoid CB1 Receptors in Nonhuman Primate Brain
Yasuno, F., Brown, A. K., Zoghbi, S. S., Krushinski, J. H., Chernet, E., Tauscher, J. T., Schaus, J. M., Phebus, L. A., Chesterfield, A. K., Felder, C. C., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301402 · Cited by 88
Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future
Panagis, G., Mackey, B., & Vlachou, S. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00092 · Cited by 87
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain
Brindisi, M., Maramai, S., Gemma, S., Brogi, S., Grillo, A., Di Cesare Mannelli, L., Gabellieri, E., Lamponi, S., Saponara, S., Gorelli, B., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01812 · Cited by 86
The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats
McLaughlin, P. J., Winston, K. M., Limebeer, C. L., Parker, L. A., Makriyannis, A., & Salamone, J. D. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2171-0 · Cited by 84
Self-citation
MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models
Naguib, M., Diaz, P., Xu, J. J., Astruc‐Diaz, F., Craig, S., Vivas‐Mejia, P., & Brown, D. L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.340 · Cited by 82
Fear relief—toward a new conceptual frame work and what endocannabinoids gotta do with it
Riebe, C. J. N., Pamplona, F. A., Kamprath, K., & Wotjak, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.057 · Cited by 84
Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways
Movsesyan, V. A., Stoica, B. A., Yakovlev, A. G., Knoblach, S. M., Lea, P. M., Černak, I., Vink, R., & Faden, A. I. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401442 · Cited by 81
Δ-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption
Stern, C. A. J., Gazarini, L., Vanvossen, A. C., Zuardi, A. W., Galve‐Roperh, I., Guimarães, F. S., Takahashi, R. N., & Bertoglio, L. J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.02.001 · Cited by 78
Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury
Johanek, L. M., & Simone, D. A. (2004) · Pain · doi:10.1016/j.pain.2004.02.020 · Cited by 78
Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat
Chambers, A. P., Sharkey, K. A., & Koopmans, H. S. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.07.004 · Cited by 78
Intrathecally applied flurbiprofen produces an endocannabinoid‐dependent antinociception in the rat formalin test
Ateş, M., Hamza, M., Seidel, K., Kotalla, C., Ledent, C. A., & Gühring, H. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02470.x · Cited by 77
Topical cannabinoid antinociception: synergy with spinal sites
Dogrul, A., Gül, H., Akar, A., Yıldız, O., Bilgin, F., & Güzeldemir, M. E. (2003) · Pain · doi:10.1016/s0304-3959(03)00068-x · Cited by 76
The endocannabinoid signaling system: Pharmacological and therapeutic aspects
Fowler, C. J., Holt, S., Nilsson, O. R., Jonsson, K., Tiger, G., & Jacobsson, S. O. P. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.023 · Cited by 76
Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex—involvement of Na+/K+-ATPase
Steffens, M., & Feuerstein, T. J. (2003) · Neurochemistry International · doi:10.1016/j.neuint.2003.08.009 · Cited by 74
The therapeutic potential of novel cannabinoid receptors
Kreitzer, F. R., & Stella, N. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.01.005 · Cited by 75
Cannabinoid CB2 receptor‐mediated regulation of impulsive‐like behaviour in DBA/2 mice
Navarrete, F., Pérez‐Ortiz, J. M., & Manzanares, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01542.x · Cited by 72
Endocannabinoid modulation of fear responses: learning and state-dependent performance effects
Reich, C. G., Mohammadi, M., & Alger, B. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107083999 · Cited by 72
The endocannabinoid system in bull sperm and bovine oviductal epithelium: role of anandamide in sperm–oviduct interaction
Gervasi, M. G., Rapanelli, M., Ribeiro, M. L., Farina, M., Billi, S. C., Franchi, A. M., & Martı́nez, S. P. (2008) · Reproduction · doi:10.1530/rep-08-0204 · Cited by 71
Cannabinoids Drugs and Oral Health—From Recreational Side-Effects to Medicinal Purposes: A Systematic Review
Bellocchio, L., Inchingolo, A. D., Inchingolo, A. M., Lorusso, F., Malcangi, G., Santacroce, L., Scarano, A., Bordea, I. R., Hazballa, D., D’Oria, M. T., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158329 · Cited by 68
Time-Dependent Protection of CB2 Receptor Agonist in Stroke
Yu, S., Reiner, D. J., Shen, H., Wu, K., Liu, Q., & Wang, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132487 · Cited by 66
Inhibition of Salivary Secretion by Activation of Cannabinoid Receptors
Prestifilippo, J. P., Fernández‐Solari, J., de la Cal, C., Iribarne, M., Suburo, Á. M., Rettori, V., McCann, S. M., & Elverdin, J. C. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100816 · Cited by 66
Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1
Mo, F. M., Offertáler, L., & Kunos, G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.034 · Cited by 65
CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat
Vlachou, S., Nomikos, G. G., & Panagis, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2050-0 · Cited by 64
CB 1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction
Wagner, J. A., Hu, K., Karcher, J. C., Bauersachs, J. K., Schäfer, A., Laser, M., Han, H. J., & Ertl, G. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705156 · Cited by 63
Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray
Lee, H.-J., Chang, L.-Y., Ho, Y., Teng, S.-F., Hwang, L.-L., Mackie, K., & Chiou, L. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.018 · Cited by 61
Antiaversive Effects of Cannabinoids: Is the Periaqueductal Gray Involved?
Moreira, F. A., de Aguiar, D. C., Campos, A. C., Lisboa, S. F. D. S., Terzian, A. L. B., Resstel, L. B. M., & Guimarães, F. S. (2008) · Neural Plasticity · doi:10.1155/2009/625469 · Cited by 62
Complex regional haemodynamic effects of anandamide in conscious rats
Gardiner, S. M., March, J. E., Kemp, P. A., & Bennett, T. M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704649 · Cited by 61
HU 210: A Potent Tool for Investigations of the Cannabinoid System
Ottani, A., & Giuliani, D. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00192.x · Cited by 60
Endocannabinoids Inhibit the Induction of Virulence in Enteric Pathogens
Ellermann, M., Pacheco, A. R., Jimenez, A. G., Russell, R. M., Cuesta, S., Kumar, A., Zhu, W., do Vale, G. D., Martin, S. A., Raj, P., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.022 · Cited by 62
Metamizol, a non‐opioid analgesic, acts via endocannabinoids in the PAG‐RVM axis during inflammation in rats
Escobar, W., Ramirez, K., Avila, C., Limongi, R., Vanegas, H., & Vázquez, E. (2011) · European Journal of Pain · doi:10.1002/j.1532-2149.2011.00057.x · Cited by 61
Developmental Effects of Cannabinoids on Zebrafish Larvae
Akhtar, M. T., Ali, S., Rashidi, H., van der Kooy, F., Verpoorte, R., & Richardson, M. K. (2013) · Zebrafish · doi:10.1089/zeb.2012.0785 · Cited by 59

Authors: Gatley, S. J., Gifford, A. N., Volkow, N. D., Lan, R., & Makriyannis, A.
Affiliations: Brookhaven National Laboratory (US)
University of Connecticut (US)
Corresponding author: Gatley, S.John
ORCID: Volkow, Nora D.
Makriyannis, Alexandros
Venue: European Journal of Pharmacology
Publisher: Elsevier BV
Published: 1996-07
Volume: 307
Issue: 3
Pages: 331-338
ISSN: 0014-2999 (ISSN-L)
DOI: 10.1016/0014-2999(96)00279-8
OpenAlex: W1979829009
Cited by: 252
References: 15
Citations by year: 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 7 · 2017: 1 · 2016: 8 · 2015: 12 · 2014: 8 · 2013: 13 · 2012: 11
FWCI: 1.49
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: European Journal of Pharmacology (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Energy
Sanofi
National Institute on Drug Abuse (DA-06278, R01DA006278, DA07515, DA-03801)
Brookhaven National Laboratory
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords: CB1 receptor, radioiodination, SR141716A, radioligand binding, brain receptor distribution, tetrahydrocannabinol, delta-9-tetrahydrocannabinol, hippocampus, striatum, cerebellum, brainstem
MeSH terms: Rimonabant, Animals, Brain, Cell Membrane, Chromatography, High Pressure Liquid, Hippocampus, Iodine Radioisotopes, Isotope Labeling, Male, Mice, Inbred Strains, Motor Activity, Piperidines, Protein Binding, Pyrazoles, Radioligand Assay, Receptors, Drug, Dronabinol, Tissue Distribution, Receptors, Cannabinoid, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks